NT-proBNP as a surrogate for unknown heart failure and its predictive power for peripheral artery disease outcome and phenotype
Abstract Patients with peripheral artery disease (PAD) are at high risk of excess mortality despite major improvements in multimodal pharmacotherapy for cardiovascular disease. However, little is known about co-prevalences and implications for the combination of heart failure (HF) and PAD. Thus, NT-...
Main Authors: | Bernhard Zierfuss, Anna Feldscher, Clemens Höbaus, Antonia Hannes, Renate Koppensteiner, Gerit-Holger Schernthaner |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-05-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-35073-z |
Similar Items
-
The integration of BNP and NT-proBNP into clinical medicine
by: Swiss Medical Weekly
Published: (2007-01-01) -
Sendaway capillary NT-proBNP in pulmonary hypertension
by: Eleanor Morris, et al.
Published: (2024-03-01) -
The Potential Role of Salivary NT-proBNP in Heart Failure
by: Aidonis Rammos, et al.
Published: (2023-08-01) -
Highly sensitive detection of NT-proBNP by molecular motor
by: Jie Zhang, et al.
Published: (2017-03-01) -
Serum NT-ProBNP potential marker of cirrhotic cardiomyopathy
by: Maya Risteska, et al.
Published: (2022-10-01)